Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-24

Clinical Trial Update: Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067 [Phase 1]

View source ↗

Summary

Phase 1 study presenting mass balance recovery, metabolite profiling, and metabolite identification data for [14C]-BIA 9-1067 in Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIA 9-1067

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED